MIRA · Categories · Form 4

MIRA - SEC Form 4 insider transactions

MIRA Pharmaceuticals Inc. (MIRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MIRA

• 70d
  SEC Form 4 filed by Aminov Erez

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 250d
  Director Shekhat Denil Nanji was granted 22,378 shares (SEC Form 4)

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 250d
  Chief Executive Officer Aminov Erez was granted 2,685,456 shares, increasing direct ownership by 318% to 3,530,156 units (SEC Form 4)

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 265d
  SEC Form 4 filed by Chief Executive Officer Aminov Erez

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 280d
  Chief Executive Officer Aminov Erez was granted 62,500 shares, increasing direct ownership by 8% to 844,700 units (SEC Form 4)

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Director Macpherson Edward Clouston

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Director Del Giudice Matthew Paul

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Chief Financial Officer Yanez Michelle

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Chief Executive Officer Aminov Erez

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Director Shekhat Denil Nanji

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 547d
  SEC Form 4 filed by Director Whalen Matthew Pratt

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 560d
  Chief Executive Officer Aminov Erez sold $133,649 worth of shares (100,000 units at $1.34), decreasing direct ownership by 9% to 1,061,200 units (SEC Form 4)

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 649d
  Large owner Mcnulty Brian Patrick sold $392,000 worth of shares (200,000 units at $1.96) (SEC Form 4)

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 719d
  SEC Form 4 filed by Director Shekhat Denil Nanji

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 741d
  SEC Form 4 filed by Aminov Erez

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Aminov Erez

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Shekhat Denil Nanji

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Yanez Michelle

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Del Giudice Matthew Paul

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Macpherson Edward Clouston

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
• 805d
  SEC Form 4 filed by Jerman Michael Allen

  4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)

Other MIRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends